Moderna announces supply agreement with south korea for additional 20 million doses of moderna's covid-19 vaccine or updated booster candidate in 2022

Agreement includes 15 million doses for delivery in the third quarter of 2022 and 5 million doses for delivery in the fourth quarter of 2022 cambridge, ma / accesswire / december 27, 2021 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced a revised supply agreement with the government of south korea for 20 million doses of moderna's covid-19 vaccine or an updated booster vaccine candidate, if authorized. under the terms of the agreement, moderna expects to deliver 15 million doses in the third quarter of 2022 and 5 million doses in the fourth quarter of 2022.
MRNA Ratings Summary
MRNA Quant Ranking